Jaguar Health Stock Forum

$Jaguar Health (JAGX.US)$ When are you going to be Acquired by Roche Holdings, Inc. so that all shareholders will be very happy....When ??

$Jaguar Health (JAGX.US)$
Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in DogsJaguar Health (NASDAQ:JAGX) is seeking a partner to develop and commercialize NP300, a second-generation antisecretory drug candidate for treating general diarrhea in dogs. NP300, derived from the Croton lechleri tree, has shown safety in dogs and shares similarities with Canalevia-CA1, the company's con...

$Jaguar Health (JAGX.US)$
Positive
Net revenue increased 14% QoQ and 11% YoY to $3.1M
Mytesi prescription volume grew 10.9% QoQ
Operating loss decreased by $1.5M YoY to $7.3M
R&D expenses reduced by $2.0M YoY to $4.0M
Negative
Net loss increased by $2.1M YoY to $9.9M
Non-GAAP Recurring EBITDA loss worsened to $9.2M from $6.2M YoY
Sales and Marketing expenses increased by $0.5M YoY
G&A expenses increased by $0.3M YoY

$Jaguar Health (JAGX.US)$
Key points, low shares outstanding, analyst target $14.50 👀, HODL! 💰

$Jaguar Health (JAGX.US)$
Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting
Jaguar Health (NASDAQ:JAGX) announced positive results from two independent investigator-initiated studies of crofelemer, presented at the American College of Gastroenterology Annual Scientific Meeting. The first study showed that crofelemer significantly decreased stool consistency and abdominal pain ...